Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Cell Mol Immunol. 2020 Jul;17(7):765-767. doi: 10.1038/s41423-020-0374-2. Epub 2020 Feb 11.

¹ Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Fudan University, Shanghai, China.
² National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
³ CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
⁴ Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
⁵ Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn.
⁶ Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA. shibojiang@fudan.edu.cn.
⁷ Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Fudan University, Shanghai, China. lul@fudan.edu.cn.

^# Contributed equally.

No abstract available

MeSH terms